Sign In
Buy SCSC
ScanSource Earnings Calls
| Release date | May 07, 2026 |
| EPS estimate | $0.91 |
| EPS actual | $0.94 |
| EPS Surprise | 3.30% |
| Revenue estimate | 738.55M |
| Revenue actual | 766.79M |
| Revenue Surprise | 3.82% |
| Release date | Feb 05, 2026 |
| EPS estimate | $1.00 |
| EPS actual | $0.80 |
| EPS Surprise | -20.00% |
| Revenue estimate | 781.25M |
| Revenue actual | 760.066M |
| Revenue Surprise | -2.71% |
| Release date | Nov 06, 2025 |
| EPS estimate | $0.91 |
| EPS actual | $1.06 |
| EPS Surprise | 16.48% |
| Revenue estimate | 787.3M |
| Revenue actual | 739.65M |
| Revenue Surprise | -6.05% |
| Release date | Aug 21, 2025 |
| EPS estimate | $0.91 |
| EPS actual | $1.02 |
| EPS Surprise | 12.09% |
| Revenue estimate | 793.8M |
| Revenue actual | 812.886M |
| Revenue Surprise | 2.40% |
Last 4 Quarters for ScanSource
Below you can see how SCSC performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 21, 2025 |
| Price on release | $39.91 |
| EPS estimate | $0.91 |
| EPS actual | $1.02 |
| EPS surprise | 12.09% |
| Date | Price |
|---|---|
| Aug 15, 2025 | $42.60 |
| Aug 18, 2025 | $42.70 |
| Aug 19, 2025 | $43.06 |
| Aug 20, 2025 | $42.53 |
| Aug 21, 2025 | $39.91 |
| Aug 22, 2025 | $44.63 |
| Aug 25, 2025 | $44.34 |
| Aug 26, 2025 | $43.57 |
| Aug 27, 2025 | $44.69 |
| 4 days before | -6.31% |
| 4 days after | 11.98% |
| On release day | 11.83% |
| Change in period | 4.91% |
| Release date | Nov 06, 2025 |
| Price on release | $41.19 |
| EPS estimate | $0.91 |
| EPS actual | $1.06 |
| EPS surprise | 16.48% |
| Date | Price |
|---|---|
| Oct 31, 2025 | $42.91 |
| Nov 03, 2025 | $42.28 |
| Nov 04, 2025 | $41.07 |
| Nov 05, 2025 | $41.87 |
| Nov 06, 2025 | $41.19 |
| Nov 07, 2025 | $40.60 |
| Nov 10, 2025 | $41.29 |
| Nov 11, 2025 | $40.65 |
| Nov 12, 2025 | $41.47 |
| 4 days before | -4.00% |
| 4 days after | 0.680% |
| On release day | -1.43% |
| Change in period | -3.34% |
| Release date | Feb 05, 2026 |
| Price on release | $36.36 |
| EPS estimate | $1.00 |
| EPS actual | $0.80 |
| EPS surprise | -20.00% |
| Date | Price |
|---|---|
| Jan 30, 2026 | $42.99 |
| Feb 02, 2026 | $44.19 |
| Feb 03, 2026 | $43.93 |
| Feb 04, 2026 | $44.33 |
| Feb 05, 2026 | $36.36 |
| Feb 06, 2026 | $38.39 |
| Feb 09, 2026 | $37.58 |
| Feb 10, 2026 | $36.71 |
| Feb 11, 2026 | $34.67 |
| 4 days before | -15.42% |
| 4 days after | -4.65% |
| On release day | 5.58% |
| Change in period | -19.35% |
| Release date | May 07, 2026 |
| Price on release | $43.40 |
| EPS estimate | $0.91 |
| EPS actual | $0.94 |
| EPS surprise | 3.30% |
| Date | Price |
|---|---|
| May 01, 2026 | $41.15 |
| May 04, 2026 | $41.27 |
| May 05, 2026 | $42.23 |
| May 06, 2026 | $40.93 |
| May 07, 2026 | $43.40 |
| May 08, 2026 | $45.90 |
| May 11, 2026 | $43.73 |
| May 12, 2026 | $43.50 |
| May 13, 2026 | $42.01 |
| 4 days before | 5.48% |
| 4 days after | -3.21% |
| On release day | 5.75% |
| Change in period | 2.09% |
ScanSource Earnings Call Transcript Summary of Q1 2026
ScanSource presented a quarter where gross profit and profitability outperformed top-line revenue growth. Management emphasized a strategic shift toward converged solutions (hardware, software and services) and investments to help channel partners transition to higher-value solution providers and technology architects. Key operational moves include expanding solutions engineering, launching AI-enabled sales tooling (Tech Checks), rolling out industry Smart Series solutions (Smart Warehouse, Smart Retail), and completing the DataXoom acquisition to scale mobile connectivity alongside last year’s Advantix deal. Financially, Q1 delivered 6% gross profit growth, 26% non-GAAP EPS growth, 5.2% adjusted EBITDA margin, strong free cash flow and 88% cash conversion of non-GAAP net income. Specialty Technology Solutions saw lower sales but higher gross profit (helped by favorable mix and supplier price actions); recurring revenue in that segment was ~13%. Intelisys & Advisory posted modest billings growth with increased SG&A investment to drive future growth. The company finished the quarter with ~ $125M cash, near-zero net debt leverage, repurchased $21M of shares, and reaffirmed FY26 guidance: net sales $3.1–3.3B, adjusted EBITDA $150–160M, and at least $80M free cash flow. Management reiterated focus on profitable growth, continued M&A discipline, and commitment to both acquisitions and share repurchases while targeting net debt leverage of 1–2x adjusted EBITDA.
